5/25 update on Zytiga failed - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

5/25 update on Zytiga failed

alperk profile image
14 Replies

To review, after 19 months on Lupron, Zytiga, prednisone, PSA increased on 1/23 to 0.253, then 0.309 on 2/21. Plarify scan showed only one active site in hip which was radiated. 4/4 PSA dropped to 0.24 which indicated the lesion was knocked out and I would be hormone sensitive and stay on Zytiga. Yea ! HOWEVER, 5/23 PSA went UP to 0.343. Now what? Am I now hormone resistant? Is Xtandi the next step ? Am I overreacting and should wait a couple of months for the next blood test. I would appreciate any thoughts from all of you.

Written by
alperk profile image
alperk
To view profiles and participate in discussions please or .
Read more about...
14 Replies
Tall_Allen profile image
Tall_Allen

Try switching to dexamethasone:

bjui-journals.onlinelibrary...

SeosamhM profile image
SeosamhM in reply to Tall_Allen

Since it worked for me, I obviously agree. This study came out in 2018... so, oh-informed-one, do you have any insight why this simple option seems to be routinely missed - or dismissed - by treatment specialists?

Tall_Allen profile image
Tall_Allen in reply to SeosamhM

A friend just had it suggested by his oncologist last week. I don't know how prevalent it is. Some oncologists stay informed more than others.

rsgdmd profile image
rsgdmd in reply to Tall_Allen

My MO had me try that, but my PSA continued to rise. Next step is one of the ...lutemides.

Tall_Allen profile image
Tall_Allen in reply to rsgdmd

I hope you mean enzalutamide and not bicalutamide.

rsgdmd profile image
rsgdmd in reply to Tall_Allen

Yea, enzalutemide, apalutemide or daralutemide.

Tall_Allen profile image
Tall_Allen in reply to rsgdmd

Only enzalutamide is approved for mCRPC, although I've seen patients get the others from agreeable insurance companies.

rsgdmd profile image
rsgdmd in reply to Tall_Allen

I've heard that....will see. Nubequa seems to have less SE than the other two.

Tall_Allen profile image
Tall_Allen in reply to rsgdmd

I'm not sure of that, also don't know which is most effective of those 3. NRG Oncology seems to prefer apalutamide. Enzalutamide has the longest history of use. Docetaxel seems to help it work longer.

Iloveyoudad profile image
Iloveyoudad in reply to Tall_Allen

Hi Sir, any thoughts on Abiraterone? My dad is currently taking Bicalutamide together with Leuprorelin. If Bicalutamide isn’t working anymore, dad needs to shift to either Xtandi or Zytiga according to urologist. Both are very expensive in my country and at the moment, dad couldn’t decide what options to take as sustainability of either is our optimum concern. Thank you

Tall_Allen profile image
Tall_Allen in reply to Iloveyoudad

abiraterone is available as a generic.

TEBozo profile image
TEBozo in reply to rsgdmd

Nubeqa is where I'm heading, I'm afraid.

TEBozo profile image
TEBozo

Mono therapy with Xtandi or Nubeqa?

Tall_Allen profile image
Tall_Allen in reply to TEBozo

Always with ADT, except in clinical trials.

You may also like...

Starting Zytiga after Xtandi failed

had any success going on to Zytiga after Xatandi? I was on Xtandi for 4 months and it did not work...

Options after Zytiga fails

been on the Magnitude clinical trial for 8 months and now Zytiga has failed. I have extensive bone...

Zytiga failed, trying chemo+Rubraca

platin). Lowest PSA was last Oct/2019 at 3 (down from 588 in Jan 2019). Jan 2020 PSA started...

PSA doubling as Zytiga failing

My PSA is doubling every month or so. This is after about 5 years of Zytiga. The cancer is...

After Zytiga-Xtandi Fail!

post by \\"Chris52981\\", after Zytiga and Xtandi fail, if chemo is the next treatment, how much...